Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 23541633)

1.

Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism.

Bonito-Oliva A, Pignatelli M, Spigolon G, Yoshitake T, Seiler S, Longo F, Piccinin S, Kehr J, Mercuri NB, Nisticò R, Fisone G.

Biol Psychiatry. 2014 May 1;75(9):701-10. doi: 10.1016/j.biopsych.2013.02.015. Epub 2013 Mar 28.

PMID:
23541633
2.

l-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via β-adrenergic receptors.

Pendolino V, Bagetta V, Ghiglieri V, Sgobio C, Morelli E, Poggini S, Branchi I, Latagliata EC, Pascucci T, Puglisi-Allegra S, Calabresi P, Picconi B.

Exp Neurol. 2014 Nov;261:377-85. doi: 10.1016/j.expneurol.2014.07.006. Epub 2014 Jul 21.

PMID:
25058044
3.

Lack of expression of long-term potentiation in the dentate gyrus but not in the CA1 region of the hippocampus of mu-opioid receptor-deficient mice.

Matthies H, Schroeder H, Becker A, Loh H, Höllt V, Krug M.

Neuropharmacology. 2000 Apr 3;39(6):952-60.

PMID:
10727705
4.

Involvement of dopamine D2 receptors in the induction of long-term potentiation in the basolateral amygdala-dentate gyrus pathway of anesthetized rats.

Abe K, Niikura Y, Fujimoto T, Akaishi T, Misawa M.

Neuropharmacology. 2008 Dec;55(8):1419-24. doi: 10.1016/j.neuropharm.2008.09.005. Epub 2008 Sep 23.

PMID:
18835399
5.

Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model.

Ho SC, Hsu CC, Pawlak CR, Tikhonova MA, Lai TJ, Amstislavskaya TG, Ho YJ.

Behav Brain Res. 2014 Jul 15;268:177-84. doi: 10.1016/j.bbr.2014.04.022. Epub 2014 Apr 19.

PMID:
24755306
6.

Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.

Lindenbach D, Dupre KB, Eskow Jaunarajs KL, Ostock CY, Goldenberg AA, Bishop C.

Brain Res. 2013 Nov 6;1537:327-39. doi: 10.1016/j.brainres.2013.09.020. Epub 2013 Sep 21.

8.

Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.

Yabuki Y, Ohizumi Y, Yokosuka A, Mimaki Y, Fukunaga K.

Neuroscience. 2014 Feb 14;259:126-41. doi: 10.1016/j.neuroscience.2013.11.051. Epub 2013 Dec 4.

PMID:
24316474
9.

Regulation of the ERK pathway in the dentate gyrus by in vivo dopamine D1 receptor stimulation requires glutamatergic transmission.

Gangarossa G, Valjent E.

Neuropharmacology. 2012 Nov;63(6):1107-17. doi: 10.1016/j.neuropharm.2012.06.062. Epub 2012 Jul 13.

PMID:
22796106
10.

Cooperation of taurine uptake and dopamine D1 receptor activation facilitates the induction of protein synthesis-dependent late LTP.

Suárez LM, Bustamante J, Orensanz LM, Martín del Río R, Solís JM.

Neuropharmacology. 2014 Apr;79:101-11. doi: 10.1016/j.neuropharm.2013.10.035. Epub 2013 Nov 10.

PMID:
24225198
11.

L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.

Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R.

Biol Psychiatry. 2014 May 1;75(9):711-22. doi: 10.1016/j.biopsych.2013.05.006. Epub 2013 Jun 13.

PMID:
23769604
12.

Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism.

Rylander D, Bagetta V, Pendolino V, Zianni E, Grealish S, Gardoni F, Di Luca M, Calabresi P, Cenci MA, Picconi B.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):E4375-84. doi: 10.1073/pnas.1311187110. Epub 2013 Oct 29.

13.

Dichotomous dopaminergic control of striatal synaptic plasticity.

Shen W, Flajolet M, Greengard P, Surmeier DJ.

Science. 2008 Aug 8;321(5890):848-51. doi: 10.1126/science.1160575.

14.

Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease.

Costa C, Sgobio C, Siliquini S, Tozzi A, Tantucci M, Ghiglieri V, Di Filippo M, Pendolino V, de Iure A, Marti M, Morari M, Spillantini MG, Latagliata EC, Pascucci T, Puglisi-Allegra S, Gardoni F, Di Luca M, Picconi B, Calabresi P.

Brain. 2012 Jun;135(Pt 6):1884-99. doi: 10.1093/brain/aws101. Epub 2012 May 4.

15.

Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.

Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M.

Synapse. 2008 Jul;62(7):524-33. doi: 10.1002/syn.20527. Erratum in: Synapse. 2008 Dec;62(12):958. Lucia, Frau [corrected to Frau, Lucia]; Annalisa, Pinna [corrected to Pinna, Annalisa]; Silvia, Pontis [corrected to Pontis, Silvia]; Nicola, Simola [corrected to Simola, Nicola]; Nicoletta, Schintu [corrected to Schintu, Nicoletta]; Micaela, Morelli [corrected to Morelli, Micaela].

PMID:
18435422
16.

D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.

Ballion B, Frenois F, Zold CL, Chetrit J, Murer MG, Gonon F.

Neurobiol Dis. 2009 Sep;35(3):376-84. doi: 10.1016/j.nbd.2009.05.019. Epub 2009 Jun 6.

PMID:
19501163
17.

Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.

Morin N, Jourdain VA, Morissette M, Grégoire L, Di Paolo T.

Neuropharmacology. 2014 Apr;79:688-706. doi: 10.1016/j.neuropharm.2014.01.014. Epub 2014 Jan 20.

PMID:
24456747
18.

Aberrant CaMKII activity in the medial prefrontal cortex is associated with cognitive dysfunction in ADHD model rats.

Yabuki Y, Shioda N, Maeda T, Hiraide S, Togashi H, Fukunaga K.

Brain Res. 2014 Apr 4;1557:90-100. doi: 10.1016/j.brainres.2014.02.025. Epub 2014 Feb 19.

PMID:
24561222
19.

Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.

Darmopil S, Martín AB, De Diego IR, Ares S, Moratalla R.

Biol Psychiatry. 2009 Sep 15;66(6):603-13. doi: 10.1016/j.biopsych.2009.04.025. Epub 2009 Jun 11.

PMID:
19520364
20.

Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington's disease.

Choi ML, Begeti F, Oh JH, Lee SY, O'Keeffe GC, Clelland CD, Tyers P, Cho ZH, Kim YB, Barker RA.

Neurobiol Dis. 2014 Jun;66:19-27. doi: 10.1016/j.nbd.2014.02.004. Epub 2014 Feb 19.

PMID:
24561069
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk